BRAINSIGNS SRL

Their core work

BrainSigns is a Rome-based SME specializing in neuroscience-based measurement and brain-computer interfaces. They develop wearable devices and neurometric tools that decode human cognitive and emotional states using EEG and related brain imaging technologies. Their work translates neuroscience research into practical applications — from assessing driver behavior for transport safety, to monitoring workload and mental states in smart environments, to detecting epileptic seizure zones in clinical settings. They bridge the gap between academic neuroscience and real-world products for healthcare, transport, and IoT sectors.

What they specialise in

How they've shifted over time

BrainSigns started in 2015 with a commercially oriented feasibility study (BrainWorkloadReader) for a compact brain workload measurement device, suggesting an early focus on productizing neuroscience tools. From 2017 onward, they diversified into applied domains — transport safety, clinical epilepsy diagnostics, aging-friendly workplaces, and IoT-connected wearables. Their trajectory shows a clear shift from single-purpose measurement devices toward integrated, wearable neurometric systems designed for real-world smart environments and healthcare.

BrainSigns is moving toward wearable, IoT-connected brain-computer interfaces for everyday environments — expect them to pursue projects combining neuroscience with ambient intelligence, digital health, and human-machine interaction.

How they like to work

BrainSigns operates as both a project leader and a specialist contributor. They coordinated 2 of their 5 projects, including their largest (Mindtooth, EUR 872K), showing they can lead consortia when the topic aligns with their core BCI expertise. With 44 unique partners across 16 countries, they maintain a broad European network rather than relying on a small circle of repeat collaborators, making them an accessible and well-connected partner for new consortia.

BrainSigns has collaborated with 44 distinct partners across 16 countries, indicating a well-distributed European network. Their partnerships span academia, clinical institutions, and industry across multiple sectors, reflecting the interdisciplinary nature of applied neuroscience.

What sets them apart

BrainSigns occupies a rare niche as a private SME that can both conduct serious neuroscience research (EEG, MEG, high-frequency oscillation analysis) and translate it into commercial products and services. Unlike university labs that publish but rarely productize, or tech companies that lack deep neuroscience expertise, BrainSigns sits at the intersection — capable of contributing rigorous brain signal processing to a consortium while also driving toward market-ready wearable devices. Their experience across health, transport, and IoT means they can bring neuroscience capability into almost any human-centered project.

Highlights from their portfolio

• Mindtooth
  Their largest project (EUR 872K) as coordinator, developing a wearable BCI device for smart environments — represents the fullest expression of their commercial vision.
• HOPE
  Demonstrates clinical-grade neuroscience capability in paediatric epilepsy diagnostics, showing depth beyond consumer/industrial applications.
• SimuSafe
  Largest consortium participation, applying behavioral neuroscience to transport safety simulation — shows ability to contribute specialist expertise to large cross-sector projects.